Literature DB >> 6314078

The perspective of GABA replenishment therapy in the epilepsies: a critical evaluation of hopes and concerns.

R G Fariello, M K Ticku.   

Abstract

Impaired GABA-mediated inhibition is probably one of the cellular abnormalities leading to Focal Epilepsy. The role of GABA in generalized seizures, particularly of Petit Mal type, is unknown. Various approaches are available to potentiate GABA function. Merits and flaws of each one of them are critically evaluated. In some forms of epilepsy, GABA agonists may replenish depleted pools, and in some others may nonspecifically raise the general excitability threshold of the brain, yet in other forms they may exert a glutamate/aspartate antagonistic effect. The available experimental evidence suggests that in bilaterally synchronous spike and wave epilepsies, GABA agonists are either ineffective or pejorative.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6314078     DOI: 10.1016/0024-3205(83)90718-x

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  5 in total

1.  Submassive hepatic necrosis associated with the use of progabide: a GABA receptor agonist.

Authors:  S J Munoz; R Fariello; W C Maddrey
Journal:  Dig Dis Sci       Date:  1988-03       Impact factor: 3.199

2.  Adaptation of the GABAA-receptor complex in rat brain during chronic elevation of GABA by ethanolamine O-sulphate.

Authors:  S Lindgren; M A Simmonds
Journal:  Br J Pharmacol       Date:  1987-07       Impact factor: 8.739

Review 3.  Critical review of the animal models of generalized epilepsies.

Authors:  R G Fariello
Journal:  Ital J Neurol Sci       Date:  1995 Feb-Mar

4.  Gamma-aminobutyrate aminotransferase activity in brains of schizophrenic patients.

Authors:  F Sherif; L Eriksson; L Oreland
Journal:  J Neural Transm Gen Sect       Date:  1992

5.  Reversal by alpha-2 agonists of diazepam withdrawal hyperactivity in rats.

Authors:  J Kunchandy; S K Kulkarni
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.